Cargando…
Case report study of the first five COVID-19 patients treated with remdesivir in France
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the virus responsible for the coronavirus disease 2019 (COVID-19) outbreak worldwide. Data on treatment are scare and parallels have been made between SARS-CoV-2 and other coronaviruses. Remdesivir is a broad-spectru...
Autores principales: | Dubert, Marie, Visseaux, Benoit, Isernia, Valentina, Bouadma, Lila, Deconinck, Laurène, Patrier, Juliette, Wicky, Paul-Henri, Le Pluart, Diane, Kramer, Laura, Rioux, Christophe, Le Hingrat, Quentin, Houhou-Fidouh, Nadhira, Yazdanpanah, Yazdan, Ghosn, Jade, Lescure, Francois-Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326458/ https://www.ncbi.nlm.nih.gov/pubmed/32619764 http://dx.doi.org/10.1016/j.ijid.2020.06.093 |
Ejemplares similares
-
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
por: Visseaux, Benoit, et al.
Publicado: (2020) -
Caractéristiques cliniques et paracliniques de 4 patients confirmés à COVID-19
por: Parisey, M., et al.
Publicado: (2020) -
Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study
por: Loubet, Paul, et al.
Publicado: (2017) -
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
por: Le Hingrat, Quentin, et al.
Publicado: (2021) -
Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’
por: Le Hingrat, Quentin, et al.
Publicado: (2021)